Blue Owl Capital Holdings LP
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 12, 2025), Blue Owl Capital Holdings LP reported 46 stock positions worth $319.9 million. Its top holding was Nuveen Churchill Direct Lend (NCDL) at 13.3% of the portfolio, followed by Blue Owl Capital (OBDC, 8.2%) and Engene (ENGN, 7.0%). Compared with Q2 2025, it opened 9 new positions, sold out of 9, added to 7 and reduced 11. The biggest buy was a new position in Roivant Sciences (ROIV) and the biggest sale Nuveen Churchill Direct Lend (NCDL, shares −23%).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001858703
- Portfolio Value
- $319.9M (Q3 2025)
- SEC Filing
- 0001193125-25-276307 ↗ filed Nov 12, 2025
Holdings Value
Holdings 46 stocks · $319.9M
| NCDL Nuveen Churchill Direct Lend | 13.34% | 3,091,553 | $42.7M | Reduce -23.5% |
| OBDC Blue Owl Capital Corp. | 8.16% | 2,045,070 | $26.1M | No change |
| ENGN Engene Holdings Inc. | 7.00% | 3,278,106 | $22.4M | Reduce -12.1% |
| LRMR Larimar Therapeutics Inc. | 5.91% | 5,853,040 | $18.9M | Add +18.8% |
| EVCM Evercommerce Inc. | 5.71% | 1,641,929 | $18.3M | No change |
| HLLY Holley Inc. | 4.77% | 4,862,361 | $15.3M | Add +18.2% |
| ROIV Roivant Sciences Ltd. | 4.67% | 988,249 | $15.0M | New |
| CGEM Cullinan Therapeutics Inc. | 4.65% | 2,510,972 | $14.9M | Add +5.2% |
| RARE Ultragenyx Pharmaceutical Inc. | 3.97% | 422,438 | $12.7M | Add +65.5% |
| CNDT Conduent Inc. | 3.90% | 4,456,848 | $12.5M | No change |
| SGMT Sagimet Biosciences Inc. Class A | 2.85% | 1,328,351 | $9.1M | No change |
| CMPX Compass Therapeutics Inc. | 2.84% | 2,591,525 | $9.1M | No change |
| DELL Dell Technologies -C | 2.32% | 52,334 | $7.4M | Add +151.0% |
| CVEO Civeo Corp. | 2.28% | 317,411 | $7.3M | No change |
| CNTX Context Therapeutics Inc. | 2.24% | 7,407,906 | $7.2M | No change |
| AQST Aquestive Therapeutics Inc. | 2.18% | 1,250,000 | $7.0M | Add +35.9% |
| IRON Disc Medicine Inc. | 2.11% | 102,260 | $6.8M | Reduce -16.4% |
| RPTX Repare Therapeutics Inc. | 1.89% | 3,443,659 | $6.1M | No change |
| PVLA Palvella Therapeutics Inc. | 1.87% | 95,259 | $6.0M | Reduce -23.9% |
| EYPT Eyepoint Inc. | 1.64% | 367,594 | $5.2M | Reduce -34.7% |
| KRRO Korro Bio Inc. | 1.57% | 105,000 | $5.0M | Reduce -16.0% |
| IMA Imagenebio Inc. | 1.38% | 540,924 | $4.4M | New |
| PLRX Pliant Therapeutics Inc. | 1.37% | 2,969,199 | $4.4M | No change |
| CNTA Centessa Pharmaceuticals Ltd. | 1.28% | 169,450 | $4.1M | Reduce -48.7% |
| IMRX Immuneering Corp. Class A | 1.20% | 550,000 | $3.9M | New |
| MLYS Mineralys Therapeutics Inc. | 1.20% | 100,944 | $3.8M | Reduce -70.0% |
| CMPS Compass Pathways PLC | 1.08% | 604,914 | $3.5M | Add +163.1% |
| ADCT Adc Therapeutics SA | 0.92% | 733,568 | $2.9M | No change |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 0.87% | 173,873 | $2.8M | New |
| MREO Mereo Biopharma Group PL-ADR | 0.81% | 1,250,000 | $2.6M | New |
| ELDN Eledon Pharmaceuticals Inc. | 0.79% | 979,912 | $2.5M | Reduce -26.3% |
| ACLX Arcellx Inc. | 0.69% | 26,823 | $2.2M | New |
| KALV Kalvista Pharmaceuticals Inc. | 0.48% | 125,000 | $1.5M | New |
| FLD Fold Holdings Inc. filed as FOLD HLDGS INC | 0.45% | 856,632 | $1.4M | No change |
| TNGX Tango Therapeutics Inc. | 0.31% | 119,416 | $1.0M | Reduce -85.3% |
| EPD Enterprise Products Partners | 0.31% | 31,290 | $978K | No change |
| GTLB Gitlab Inc. Class A | 0.17% | 12,352 | $557K | New |
| SHFS SHF Holdings Inc. | 0.17% | 75,897 | $543K | No change |
| TTAN Servicetitan Inc. Class A | 0.16% | 4,954 | $500K | Reduce -56.4% |
| MRKR Marker Therapeutics Inc. | 0.15% | 554,250 | $495K | No change |
| ALPHA MODUS HLDGS INC | 0.14% | 394,078 | $454K | No change |
| CAH Cardinal Health Inc. | 0.08% | 1,718 | $270K | No change |
| PIPR Piper Sandler Cos | 0.07% | 607 | $211K | New |
| AEON Aeon Biopharma Inc. | 0.01% | 42,353 | $34K | No change |
| ENGENE HOLDINGS INC | 0.01% | 36,100 | $26K | No change |
| VRNA Verona Pharma Ltd. | 0.00% | 18,347 | $98 | No change |
Other holdings (26): bonds, preferreds, convertibles and warrants · $2.2M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | 546,442 | $1.0M | No change |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | 292,930 | $470K | Reduce -38.5% |
| SLND.WS Legato Merger Corp. II -CW23 | *W EXP 02/14/202 | 860,302 | $166K | No change |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | 1,854,665 | $144K | No change |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | 175,000 | $80K | No change |
| OPTXW Omnilit Acquisition Class A -23 | *W EXP 99/99/999 | 803,132 | $70K | No change |
| BKSYW Blacksky Technology -CW24 | *W EXP 09/09/202 | 350,000 | $59K | No change |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | 300,000 | $46K | No change |
| DAVEW Dave Inc. -CW27 | *W EXP 01/05/202 | 28,750 | $31K | No change |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | 400,000 | $29K | No change |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | 1,666,808 | $26K | No change |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | 48,661 | $24K | No change |
| RDZNW Vahanna Tech Edge -CW24 | *W EXP 11/30/202 | 225,000 | $16K | No change |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 200,000 | $14K | No change |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | 250,000 | $14K | No change |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | 50,000 | $12K | No change |
| TVGNW Semper Paratus Acqu -CW26 | *W EXP 02/14/202 | 200,000 | $11K | No change |
| LIMNW Liminatus Pharma Inc. Class A-28 | *W EXP 04/30/203 | 50,000 | $7K | No change |
| BDMDW Baird Medical Investment -28 | *W EXP 10/01/202 | 100,000 | $7K | No change |
| BSLKW Golden Arrow Merger A -CW26 | *W EXP 08/13/202 | 166,666 | $7K | No change |
| CEROW Phoenix Biotech Acq -CW26 | *W EXP 02/13/202 | 224,930 | $3K | No change |
| KPLTW Katapult Holdings Inc. -CW26 | *W EXP 06/09/202 | 400,000 | $3K | No change |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | 50,000 | $1K | No change |
| MLKWF Waldencast Acq Class A -CW27 | *W EXP 07/27/202 | 33,333 | $1K | No change |
| XBPEW CF Acquisition Viii A -CW27 | *W EXP 11/30/202 | 24,778 | $994 | No change |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | 16,666 | $447 | No change |
Total filed on the 13F, all lines: $322.1M.
Portfolio Sells Q2 2025 → Q3 2025
| NCDL Nuveen Churchill Direct Lend | Reduce -23.5% | 13.34% | −7.88 |
| TRML Tourmaline Bio Inc. | Sold out | 0.00% | −5.17 |
| IKENA ONCOLOGY INC | Sold out | 0.00% | −1.78 |
| TEM Tempus AI Inc. Class A | Sold out | 0.00% | −1.65 |
| TNGX Tango Therapeutics Inc. | Reduce -85.3% | 0.31% | −1.04 |
| STWD Starwood Property Trust Inc. | Sold out | 0.00% | −0.86 |
| BMEA Biomea Fusion Inc. | Sold out | 0.00% | −0.76 |
| CABA Cabaletta Bio Inc. | Sold out | 0.00% | −0.55 |
| APGE Apogee Therapeutics Inc. | Sold out | 0.00% | −0.49 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -26.3% | 0.79% | −0.38 |
| MLYS Mineralys Therapeutics Inc. | Reduce -70.0% | 1.20% | −0.28 |
| TTAN Servicetitan Inc. Class A | Reduce -56.4% | 0.16% | −0.24 |
| RZLV Rezolve AI PLC | Sold out | 0.00% | −0.18 |
| CNTA Centessa Pharmaceuticals Ltd. | Reduce -48.7% | 1.28% | −0.12 |
| EYPT Eyepoint Inc. | Reduce -34.7% | 1.64% | −0.08 |
| KPLT Katapult Holdings Inc. | Sold out | 0.00% | −0.00 |
| IRON Disc Medicine Inc. | Reduce -16.4% | 2.11% | +0.01 |
| PVLA Palvella Therapeutics Inc. | Reduce -23.9% | 1.87% | +0.95 |
| KRRO Korro Bio Inc. | Reduce -16.0% | 1.57% | +1.07 |
| ENGN Engene Holdings Inc. | Reduce -12.1% | 7.00% | +2.60 |
Portfolio Buys Q2 2025 → Q3 2025
| ROIV Roivant Sciences Ltd. | New | 4.67% | +4.67 |
| HLLY Holley Inc. | Add +18.2% | 4.77% | +2.10 |
| DELL Dell Technologies -C | Add +151.0% | 2.32% | +1.49 |
| IMA Imagenebio Inc. | New | 1.38% | +1.38 |
| LRMR Larimar Therapeutics Inc. | Add +18.8% | 5.91% | +1.29 |
| IMRX Immuneering Corp. Class A | New | 1.20% | +1.20 |
| AQST Aquestive Therapeutics Inc. | Add +35.9% | 2.18% | +1.20 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +65.5% | 3.97% | +0.96 |
| CMPS Compass Pathways PLC | Add +163.1% | 1.08% | +0.87 |
| NU Nu Holdings Ltd./Cayman Isl-A | New | 0.87% | +0.87 |
| MREO Mereo Biopharma Group PL-ADR | New | 0.81% | +0.81 |
| ACLX Arcellx Inc. | New | 0.69% | +0.69 |
| KALV Kalvista Pharmaceuticals Inc. | New | 0.48% | +0.48 |
| GTLB Gitlab Inc. Class A | New | 0.17% | +0.17 |
| PIPR Piper Sandler Cos | New | 0.07% | +0.07 |
| CGEM Cullinan Therapeutics Inc. | Add +5.2% | 4.65% | −1.17 |
Notes & Other Activity Q2 2025 → Q3 2025
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | Reduce -38.5% | 292,930 | $470K |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 48 | $656.7M | SPCX, AKTS, CGEM, LRMR, NCDL |
| Q1 2026 | 54 | $369.9M | AKTS, LRMR, ENGN, NCDL, CGEM |
| Q4 2025Amended | 50 | $320.9M | ENGN, NCDL, OBDC, LRMR, CGEM |
| Q3 2025 | 46 | $319.9M | NCDL, OBDC, ENGN, LRMR, EVCM |
| Q2 2025 | 46 | $308.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q1 2025 | 45 | $309.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q4 2024 | 48 | $432.6M | NCDL, KVYO, PLRX, OBDC, CGEM |
| Q3 2024 | 68 | $514.6M | NCDL, KVYO, TRML, PLRX, CGEM |
| Q2 2024 | 40 | $359.5M | CGEM, PLRX, OBDC, KVYO, LRMR |
| Q1 2024 | 44 | $500.6M | HOOD, CGEM, PLRX, ENGN, TRML |